Precision BioSciences to Host Investor Webcast to Discuss Late-Breaking PBGENE-HBV Data from ELIMINATE-B Trial Presented at European Association for the Study of the Liver Congress 2026

Go back to Precision BioSciences to Host Investor Webcast to Discuss Late-Breaking PBGENE-HBV Data from ELIMINATE-B Trial Presented at European Association for the Study of the Liver Congress 2026
(NASDAQ: DTIL) Delayed: 7.08 --0 (-0%)
Previous Close $7.08    52 Week High
Open $7.08    52 Week Low
Day High $7.08    P/E N/A 
Day Low $7.08    EPS
Volume 41